INmune Bio Inc.
Last updated September 27, 2026
Organization details
- Legal name
- INmune Bio Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Boca Raton
- Headquarters state / province
- Florida
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- INMB
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001711754
- EIN
- 47-5205835
Board of directors
-
David J. Moss · Director · Chief Executive OfficerSince 2025
-
Edgardo Baracchini Jr. · DirectorSince 2023
-
James Kelly Ganjei · DirectorSince 2023
-
James Sapirstein · DirectorSince 2026
-
Marcia Allen · DirectorSince 2023
-
Raymond Joseph Tesi · Director · President and CEOSince 2023
-
Ronnie Duane Clark · DirectorSince 2026
-
Scott Juda · DirectorSince 2023
-
Timothy J. Schroeder · DirectorSince 2023
Chief executives
Raymond Joseph Tesi
· President and CEO
Dates unknown
David J. Moss
· Chief Executive Officer
Dates unknown
Director election results
Annual meeting of June 16, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
66.5%
-
70.8%
-
74.0%
-
76.3%
-
83.8%
Board connections
1 of this board's directors also sit on 3 other boards.
- via James Sapirstein
- via James Sapirstein
- via James Sapirstein
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 2, 2026 | David J. Moss Director, Officer (Chief Executive Officer) | Option exercise | +9,014 | $1.40 | $12,620 |
| Jul 2, 2026 | Lowdell Mark William Officer (Chief Scientific Officer) | Option exercise | +7,211 | $1.40 | $10,095 |
| Jul 2, 2026 | Scott Juda Director | Option exercise | +14,801 | $1.40 | $20,721 |
| Sep 30, 2024 | Moss David J Officer (Chief Financial Officer), 10% owner | Open-market purchase | +10,000 | $5.29 | $52,900 |
| Sep 12, 2024 | Raymond Joseph Tesi Director, Officer (President and CEO), 10% owner | Open-market purchase | +15,380 | $6.38 | $98,124 |
| Sep 12, 2024 | Moss David J Officer (Chief Financial Officer), 10% owner | Open-market purchase | +7,690 | $6.38 | $49,062 |
| Jun 25, 2024 | Scott Juda Director | Open-market purchase | +5,000 | $7.27 | $36,350 |
| Apr 19, 2024 | Raymond Joseph Tesi Director, Officer (President and CEO), 10% owner | Grant or award | +18,028 | $8.32 | $149,993 |
| Apr 19, 2024 | Moss David J Officer (CFO, Treasurer & Secretary), 10% owner | Grant or award | +18,028 | $8.32 | $149,993 |
| Apr 19, 2024 | Lowdell Mark William Officer (Chief Scientific Officer), 10% owner | Grant or award | +14,423 | $8.32 | $119,999 |
| Apr 19, 2024 | Scott Juda Director | Grant or award | +29,603 | $8.32 | $246,297 |
| Nov 10, 2023 | Scott Juda Director | Open-market purchase | +7,000 | $6.95 | $48,650 |
| Jul 12, 2023 | Timothy J. Schroeder Director | Open-market sale | −10,000 | $11.01 | $110,100 |
| Mar 17, 2023 | Moss David J Officer (CFO, Treasurer & Secretary), 10% owner | Open-market purchase | +2,500 | $6.43 | $16,075 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.